Blogs
Where can you buy Ozempic, Rybelsus, or Wegovy online?
Where can you buy Ozempic, Rybelsus, or Wegovy online?
Ozempic, Rybelsus, and Wegovy are all semaglutide. Novo Nordisk manufactures all three drugs. Here is a handy table comparing the three medications.
| Rybelsus | Ozempic | Wegovy | |
| Active ingredient | Semaglutide | Semaglutide | Semaglutide |
| Medical indication | Type 2 diabetes | Type 2 diabetes | Weight Management |
| Dosing | Once daily, 3, 7, or 14 mg | Weekly 0.25, 0.5 or 1mg | Weekly 0.25, 0.5, 1.7 or 2.4 mg |
| Form | Oral pill | Injectable | Injectable |
| Most common side effects | Gastrointestinal | Gastrointestinal | Gastrointestinal |
| Prices on GoodRx | $886 to $928 | $886 to $922 | $1327 to $1401 |
The Pipeline of Weight Management Drugs
More semaglutide combinations and other weight management drugs are being developed, promising even greater weight loss. A combination of a human amylin analogue and semaglutide resulted in a 15% to 17% weight loss in just 20 weeks, with no evidence that weight loss would slow.
Tirzepatide is a gastric inhibitory peptide/ GLP-1 receptor agonist that resulted in more than 10% weight loss and a decline in HgA1c results by 2.5%. Over half of the participants in the clinical trial achieved normal glucose levels.
Setmelanotide is an Mc4R agonist targeted for people with congenital obesity who carry the MC4R loss of function gene variant. Setmelanitide is FDA-approved for patients age six and older with obesity secondary to POMC, PCSK1, and LEPR deficiency.
Oral superabsorbent hydrogel (Gelesis) is biodegradable and food-quality. As it expands to simulate fullness, people experience less hunger. Clinical trial results show at least 5% weight loss, with one-fourth achieving 10% or more. Brand name, Plenity, comes in a capsule that is released in the stomach. The cellulose released from the capsule absorbs water. Plenity can hold up to 100 times its weight in water. Plenity is indicated for adults with a BMI of 25 to 40, in conjunction with a healthy diet and exercise.
Finally, bimagrumab is a monoclonal antibody against activin type II receptors. In a clinical trial that enrolled people with type 2 diabetes, participants lost 20.5% of their total body fat mass and had a 3.6% increase in lean mass.
